Andreas Engert
Impact in
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 94
- Genetics 35
- Chronic Lymphocytic Leukemia Research 29
- Co-authors
- Volker DiehlCorinne BrillantRenaud CapdevilleCorinne HaïounDengyan MaPeter JohnsonF ReyesNicolas Ketterer
- Journals
- Blood (24 papers)Journal of Clinical Oncology (13 papers)Annals of Oncology (11 papers)JNCI Journal of the National Cancer Institute (7 papers)HemaSphere (7 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Andreas Engert
168 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Pathology and Forensic Medicine 2.3k
- Genetics 901
- Oncology 1.8k
- Immunology 997
- Neurology 657
Countries citing papers authored by Andreas Engert
This map shows the geographic impact of Andreas Engert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Engert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Engert more than expected).
Fields of papers citing papers by Andreas Engert
This network shows the impact of papers produced by Andreas Engert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Engert. The network helps show where Andreas Engert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas Engert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2020 | 8 | |
| 3 | 2019 | 2 | |
| 4 | B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG) | 2018 | 0 |
| 5 | 2014 | 1 | |
| 6 | 2012 | 3 | |
| 7 | Entwicklung von Anti-CD30-Radioimmunkonstrukten zur Behandlung des Hodgkin-Lymphoms – Studien an Zellkulturen und Tieren | 2010 | 6 |
| 8 | Reformperspektiven einer Umwandlung von Fremd- in Eigenkapital (Debt-Equity Swap) im Insolvenzplanverfahren | 2009 | 1 |
| 9 | Vom Wert der Wahlfreiheit: Eine empirische Analyse der Societas Europaea als Rechtsformalternative | 2009 | 3 |
| 10 | 2009 | 21 | |
| 11 | 2009 | 1 | |
| 12 | Increased doses of an anti-CD30 antibody, MDX-060, results in prolonged progression free survival in subjects with CD30 positive lymphoma. | 2008 | 2 |
| 13 | 2006 | 16 | |
| 14 | 2004 | 112 | |
| 15 | 2-weekly vs 3-weekly CHOP with and without Etoposide in Young Patients with Low-Risk Aggressive Non-Hodgkins Lymphoma Results of the Completed NHL-B-1 Trial of the DSHNHL | 2002 | 1 |
| 16 | 2002 | 30 | |
| 17 | Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: Superior results in patients younger than 60 years | 2001 | 1 |
| 18 | 2001 | 2 | |
| 19 | 1994 | 1 | |
| 20 | 1994 | 10 |
About Andreas Engert
Andreas Engert is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 179 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (94 papers), Lung Cancer Treatments and Mutations (37 papers), Monoclonal and Polyclonal Antibodies Research (35 papers), Chronic Lymphocytic Leukemia Research (29 papers), CAR-T cell therapy research (15 papers), Toxin Mechanisms and Immunotoxins (14 papers), CNS Lymphoma Diagnosis and Treatment (13 papers) and Corporate Governance and Law (10 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.3k citations), Genetics (901 citations), Oncology (1.8k citations), Immunology (997 citations) and Neurology (657 citations). Andreas Engert has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Volker Diehl, Corinne Brillant, Renaud Capdeville, Corinne Haïoun, Dengyan Ma, Peter Johnson, F Reyes, Nicolas Ketterer, Michaela Feuring Buske and H Tilly. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, JNCI Journal of the National Cancer Institute and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.